IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Drug Metabolism

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.21

h-Index

2022-2023

 118

Rank

2022-2023

 9007

SJR

2022-2023

 0.574

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Drug Metabolism
Abbreviation Curr. Drug Metab.
Publication Type Journal
Subject Area, Categories, Scope Clinical Biochemistry (Q2); Pharmacology (Q2)
h-index 118
Overall Rank/Ranking 9007
SCImago Journal Rank (SJR) 0.574
Impact Score 2.21
Publisher Bentham Science Publishers B.V.
Country Netherlands
ISSN 18755453, 13892002
Best Quartile Q2
Coverage History 2000-2022




Aim and Scope


Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability.


About Current Drug Metabolism


Current Drug Metabolism is a journal covering the technologies/fields/categories related to Clinical Biochemistry (Q2); Pharmacology (Q2). It is published by Bentham Science Publishers B.V.. The overall rank of Current Drug Metabolism is 9007. According to SCImago Journal Rank (SJR), this journal is ranked 0.574. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 118. The best quartile for this journal is Q2.

The ISSN of Current Drug Metabolism journal is 18755453, 13892002. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Drug Metabolism is cited by a total of 1094 articles during the last 3 years (Preceding 2022).


Current Drug Metabolism Impact IF 2022-2023


The Impact IF 2022 of Current Drug Metabolism is 2.21, which is computed in 2023 as per its definition. Current Drug Metabolism IF is decreased by a factor of 0.96 and approximate percentage change is -30.28% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Drug Metabolism Impact IF 2023 Prediction


Impact IF 2022 of Current Drug Metabolism is 2.21. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Current Drug Metabolism. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.21
2021 3.17
2020 3.42
2019 2.67
2018 2.35
2017 2.73
2016 2.78
2015 3.11
2014 3.21

Current Drug Metabolism h-index


  Table Setting

Current Drug Metabolism has an h-index of 118. It means 118 articles of this journal have more than 118 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Drug Metabolism ISSN


The ISSN of Current Drug Metabolism is 18755453, 13892002. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Drug Metabolism Rank and SCImago Journal Rank (SJR)


The overall rank of Current Drug Metabolism is 9007. According to SCImago Journal Rank (SJR), this journal is ranked 0.574. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Drug Metabolism by Year


Year SJR
2023/2024 Coming Soon
2022 0.574
2021 0.620
2020 0.667
2019 0.650
2018 0.544
2017 0.833
2016 0.881
2015 0.977
2014 1.014

Ranking of Current Drug Metabolism by Year


Year Ranking
2023/2024 Coming Soon
2022 9007
2021 7958
2020 7496
2019 7562
2018 8819
2017 5549
2016 5190
2015 4583
2014 4246

Current Drug Metabolism Publisher


Table Setting

Current Drug Metabolism is published by Bentham Science Publishers B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2000-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Drug Metabolism is Curr. Drug Metab.. This abbreviation ('Curr. Drug Metab.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Drug Metabolism


If your research field is/are related to Clinical Biochemistry (Q2); Pharmacology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Drug Metabolism?

Current Drug Metabolism latest impact IF is 2.21. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 3.42 (2020) and 2.21 (2022), respectively, in the last 9 years. Moreover, its average IS is 2.85 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Current Drug Metabolism?

The Current Drug Metabolism has an SJR (SCImago Journal Rank) of 0.574, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.014 in 2014 and the lowest being 0.544 in 2018. Furthermore, the average SJR of the Current Drug Metabolism over the previous 9-year period stands at 2.85.


What's the latest h-index of the Current Drug Metabolism?

The latest h-index of the Current Drug Metabolism is 118.


Who's the publisher of the Current Drug Metabolism?

The Current Drug Metabolism is published by the Bentham Science Publishers B.V., with its country of publication being the Netherlands.


What's the current ranking of the Current Drug Metabolism?

The Current Drug Metabolism is currently ranked 9007 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4246 in 2014 and its lowest position of 9007 in 2022.


What's the abbreviation or short name for the Current Drug Metabolism?

The standard ISO4 abbreviation for the Current Drug Metabolism is Curr. Drug Metab..


Is the "Current Drug Metabolism" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Drug Metabolism is classified as a journal that the Bentham Science Publishers B.V. publishes.


What's the scope or major areas of the Current Drug Metabolism?

The Current Drug Metabolism encompasses the following areas:

  • Clinical Biochemistry
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Drug Metabolism?

The Current Drug Metabolism is assigned the following International Standard Serial Numbers (ISSN): 18755453, 13892002.


What's the best quartile of the Current Drug Metabolism?

The best quartile for the Current Drug Metabolism is Q2 (2022).


What's the coverage history of the Current Drug Metabolism?

The Current Drug Metabolism coverage history can be summarized as follows: 2000-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Analysis in Theory and Applications journal 19346 Springer Netherlands 11 0.00
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Journal of Applied Business Research journal 23890 29 0.28
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
Canadian Journal of Education journal 17961 Canadian Society for the Study of Education (CSSE) 41 0.39
International Journal of Research and Method in Education journal 5180 Taylor and Francis Ltd. 34 2.49
Studies in Continuing Education journal 6011 Routledge 38 2.81
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS conference and proceedings 781 Association for Computing Machinery (ACM) 100 8.01
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
HOMO- Journal of Comparative Human Biology journal 19810 Elsevier BV 35 0.56

Check complete list




Year wise Impact Score (IS) of Current Drug Metabolism

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.21
2021 3.17
2020 3.42
2019 2.67
2018 2.35
2017 2.73
2016 2.78
2015 3.11
2014 3.21



Top Journals/Conferences in Clinical Biochemistry

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Redox Biology
Elsevier BV | Netherlands

Biomarker Research
BioMed Central Ltd. | United Kingdom

Angiogenesis
Springer Netherlands | Netherlands

Critical Reviews in Clinical Laboratory Sciences
Informa Healthcare | United Kingdom

American Journal of Respiratory Cell and Molecular Biology
American Thoracic Society | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All